logo
Why Newmont Stock Jumped 26% Amid Market Volatility This Week

Why Newmont Stock Jumped 26% Amid Market Volatility This Week

Yahoo13-04-2025
In what might go down as one of the wildest weeks for investors in stocks in recent history, Newmont (NYSE: NEM) stock offered much respite, with solid and steady gains through the week. Shortly after noon ET Friday, Newmont stock hit a weekly intraday high of 26%, according to data provided by S&P Global Market Intelligence. The S&P 500 (SNPINDEX: ^GSPC), meanwhile, managed to log 6.1% gains, at its intraday best over the past five trading days, through 2 p.m. ET Friday
Newmont stock is riding the wave of fresh enthusiasm in gold stocks amid the stock market turmoil, with one analyst even upgrading the stock's price target by 20%.
Newmont is the world's largest gold producer, with its mines churning out 6.8 million attributable ounces of gold in 2024. The mining giant also produces silver, copper, zinc, and lead.
As one may guess, Newmont's fortunes depend on commodity prices, and we are witnessing gold's golden days right now. Gold is on fire, with its price hitting a record high this morning and jumping over $3,220 per ounce. Analysts at UBS just predicted gold prices to hit $3,500 per ounce in 2026 as investors flock to the yellow metal amid the tariffs and trade war that have triggered fears of a recession.
At the same time, analyst Daniel Major lifted Newmont stock's rating to buy from neutral and upped its price target to $60 per share from $50 a share. That would mean a 20% upside from the gold stock's closing price of April 10. Major believes Newmont stock could get a lift as the miner achieves its 2025 guidance amid low expectations.
Newmont stock has hugely underperformed the industry and gold prices in recent years as operational challenges and high costs hit the miner's profits and cash flows. 2024, however, was a strong year for Newmont. Having acquired Newcrest in 2023, Newmont's sales jumped 57% in 2024, and it turned a net profit of $3.4 billion versus a net loss of nearly $2.5 billion in 2023.
Newmont is also cutting debt, and expects to raise net cash proceeds of around $2.5 billion from the sale of some assets this year. A UBS analyst believes the miner could return much of this cash to shareholders in the form of share buybacks.
I'm not too sure here, though. While soaring gold prices should send Newmont's sales up in 2025, I'm still wary about its mining and production costs and expect them to remain high this year. That means other, even smaller, gold stocks, might be able to better exploit gold prices to their advantage and grow faster than Newmont.
Before you buy stock in Newmont, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Newmont wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $496,779!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $659,306!*
Now, it's worth noting Stock Advisor's total average return is 787% — a market-crushing outperformance compared to 152% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of April 5, 2025
Neha Chamaria has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Why Newmont Stock Jumped 26% Amid Market Volatility This Week was originally published by The Motley Fool
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery
Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery

Yahoo

time15 minutes ago

  • Yahoo

Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery

Eli Lilly and Company (NYSE:LLY) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 14, Reuters reported that Eli Lilly and Company (NYSE:LLY) has entered into a deal worth $1.3 billion with Superluminal Medicines, a privately held company. The aim of this deal is to use AI to discover and develop small-molecule drugs for obesity and other cardiometabolic diseases. As per the report by Reuters, Eli Lilly and Company (NYSE:LLY) is already leading the obesity treatment market, which is expected to be worth $150 billion by the next decade. The company is looking to solidify its foothold in this area by developing next-generation drugs, making acquisitions, and entering into partnerships. The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates discovered with the help of Superluminal's proprietary AI-driven platform targeting G-protein-coupled receptors (GPCR). These proteins can influence physiological processes including metabolism, cell growth, and immune responses. Eli Lilly and Company (NYSE:LLY) is an American multinational pharmaceutical company focused on discovering, developing, and delivering innovative medicines. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Revenue Growth Stocks to Buy Now and 14 Best Aggressive Growth Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey.

New Buy Rating for Block (XYZ), the Technology Giant
New Buy Rating for Block (XYZ), the Technology Giant

Business Insider

time17 minutes ago

  • Business Insider

New Buy Rating for Block (XYZ), the Technology Giant

Evercore ISI analyst Adam Frisch maintained a Buy rating on Block yesterday and set a price target of $96.00. The company's shares closed yesterday at $74.30. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Frisch covers the Technology sector, focusing on stocks such as Block, Shift4 Payments, and Toast Inc. According to TipRanks, Frisch has an average return of 36.0% and a 100.00% success rate on recommended stocks. In addition to Evercore ISI, Block also received a Buy from TR | OpenAI – 4o's Elisa Scalantra in a report issued yesterday. However, on August 14, Compass Point maintained a Sell rating on Block (NYSE: XYZ). Based on Block's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $6.05 billion and a net profit of $538.46 million. In comparison, last year the company earned a revenue of $6.16 billion and had a net profit of $195.27 million Based on the recent corporate insider activity of 114 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of XYZ in relation to earlier this year. Last month, Owen Britton Jennings, the Business Lead of XYZ sold 1,050.00 shares for a total of $72,723.00.

Palantir (PLTR) Leads Selloff in Technology Stocks
Palantir (PLTR) Leads Selloff in Technology Stocks

Business Insider

time17 minutes ago

  • Business Insider

Palantir (PLTR) Leads Selloff in Technology Stocks

The stock of Palantir Technologies (PLTR) is down 10% on Aug. 19 and leading the technology sector lower. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In fact, PLTR stock is the worst performer in the benchmark S&P 500 index amid a broad selloff in technology names that also includes Nvidia (NVDA), Meta Platforms (META), and Microsoft (MSFT). The decline in Palantir's stock comes after a big rally in the share price that began when the data analytics firm reported blowout financial results in early August. PLTR stock is still up 110% on the year and one of the strongest equity performers in the U.S. However, some analysts worry that the current pullback could be the start of a rerating among richly valued technology companies whose stocks have been running hot since the recovery from the April low this year that was sparked by U.S. President Donald Trump's tariffs. Downdraft Palantir's stock has now declined for five consecutive trading days, pulling its share price 12% lower over that period. There's been no obvious catalyst or reason for the current selloff. Some analysts on Wall Street are attributing it to profit taking after a big run-up in the share price. Others say that the downturn is due to a potential pullback in stocks related to the artificial intelligence (AI) trade and worries that the U.S. Federal Reserve may hold interest rates higher for longer than hoped. Regardless of the reason, the current drop in PLTR stock comes after a 440% gain over the past year. Palantir has been riding high on strong earnings, government contract wins, and excitement about AI. Is PLTR Stock a Buy? The stock of Palantir has a consensus Hold rating among 20 Wall Street analysts. That rating is based on five Buy, 13 Hold, and two Sell recommendations issued in the last three months. The average PLTR price target of $156.78 implies 0.80% downside from current levels.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store